CO5690618A2 - THERAPEUTIC AGENT FOR MESOTELIOMA - Google Patents
THERAPEUTIC AGENT FOR MESOTELIOMAInfo
- Publication number
- CO5690618A2 CO5690618A2 CO06044336A CO06044336A CO5690618A2 CO 5690618 A2 CO5690618 A2 CO 5690618A2 CO 06044336 A CO06044336 A CO 06044336A CO 06044336 A CO06044336 A CO 06044336A CO 5690618 A2 CO5690618 A2 CO 5690618A2
- Authority
- CO
- Colombia
- Prior art keywords
- mesothelioma
- therapeutic agent
- antibody
- receptor
- mesotelioma
- Prior art date
Links
Landscapes
- Hardware Redundancy (AREA)
- Programmable Controllers (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
1.- Un agente terapéutico para el mesotelioma que contiene un antagonista de la interleuquina-6 (IL-6) como su ingrediente activo.2.- Un agente terapéutico para el mesotelioma de acuerdo con la reivindicación 1 en la cual el mesotelioma es el mesotelioma de pleura.3.- Un agente terapéutico para el mesotelioma de acuerdo con la reivindicación 2 en la cual el mesotelioma de pleura es el mesotelioma de pleura maligno.4.- Un agente terapéutico para el mesotelioma de acuerdo con cualquiera de las reivindicaciones 1 a 3 en las cuales el antagonista de IL-6 es el anticuerpo para el receptor de IL-6.5.- Un agente terapéutico para el mesotelioma de acuerdo con la reivindicación 4 en la cual el anticuerpo para el receptor de IL-6 es el anticuerpo monoclonal para el receptor de IL-6.6.- Un agente terapéutico para el mesotelioma de acuerdo con la reivindicación 4 en la cual el anticuerpo para el receptor de IL-6 es el anticuerpo monoclonal para el receptor de IL-6 humano.7.- Un agente terapéutico para el mesotelioma de acuerdo con la reivindicación 4 en la cual el anticuerpo para el receptor de IL-6 es el anticuerpo monocional para el receptor de IL-6 de ratón.8.- Un agente terapéutico para el mesotelioma de acuerdo con cualquiera de las reivindicaciones 4 a 7 en las cuales el anticuerpo para el receptor de IL-6 es el anticuerpo recombinante.1. A therapeutic agent for mesothelioma containing an interleukin-6 antagonist (IL-6) as its active ingredient. 2. A therapeutic agent for mesothelioma according to claim 1 wherein the mesothelioma is the Pleura mesothelioma. 3. A therapeutic agent for mesothelioma according to claim 2 wherein the pleura mesothelioma is malignant pleural mesothelioma. 4. A therapeutic agent for mesothelioma according to any of claims 1. to 3 in which the IL-6 antagonist is the antibody for the IL-6.5 receptor. - A therapeutic agent for mesothelioma according to claim 4 in which the antibody for the IL-6 receptor is the antibody. monoclonal for the IL-6.6 receptor. A therapeutic agent for mesothelioma according to claim 4 wherein the antibody for the IL-6 receptor is the monoclonal antibody for the human IL-6 receptor. An agent for mesothelioma according to claim 4, in which the antibody for the IL-6 receptor is the monoclonal antibody for the mouse IL-6 receptor. 8 .- A therapeutic agent for mesothelioma according to any of claims 4 to 7 in which the antibody for the IL-6 receptor is the recombinant antibody.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003358162A JP2004094966A (en) | 2003-10-17 | 2003-10-17 | Computer and computer system |
Publications (1)
Publication Number | Publication Date |
---|---|
CO5690618A2 true CO5690618A2 (en) | 2006-10-31 |
Family
ID=32064633
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO06044336A CO5690618A2 (en) | 2003-10-17 | 2006-05-10 | THERAPEUTIC AGENT FOR MESOTELIOMA |
Country Status (2)
Country | Link |
---|---|
JP (1) | JP2004094966A (en) |
CO (1) | CO5690618A2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4910604B2 (en) * | 2006-09-28 | 2012-04-04 | 富士電機株式会社 | Slave device |
JP4852070B2 (en) * | 2008-06-16 | 2012-01-11 | 三菱電機株式会社 | Plant monitoring and control system |
US8762994B2 (en) * | 2010-08-26 | 2014-06-24 | Intel Corporation | Power-optimized interrupt delivery |
-
2003
- 2003-10-17 JP JP2003358162A patent/JP2004094966A/en active Pending
-
2006
- 2006-05-10 CO CO06044336A patent/CO5690618A2/en unknown
Also Published As
Publication number | Publication date |
---|---|
JP2004094966A (en) | 2004-03-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0208636A (en) | Therapeutic agent for chronic arthritic diseases of childhood-related diseases | |
CL2008002207A1 (en) | Pharmaceutical composition comprising immunosuppressants to improve the effect in the use of an antagonist of interleukin-6 (il-6) for the treatment of illnesses related to il-6 (div. Sol. 896-04). | |
AR046290A1 (en) | THERAPEUTIC AGENT FOR MESOTELIOMA | |
BRPI0417072A (en) | preventive agent for vasculitis | |
ECSP077421A (en) | COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF THE ACTIVITY OF THE CANABINOID RECEIVER 1 | |
ATE556060T1 (en) | MONOCYCLIC ANILIDE SPIROHYDANTOINS AS CGRP RECEPTOR ANTAGONISTS | |
CL2008001659A1 (en) | Quinoxaline derived compounds as inhibitors of the tyrosine kinase activity of janus kinases; pharmaceutical composition comprising said compounds; and its use to treat an immunological disease selected from organ transplant rejection, lupus, multiple sclerosis, among other diseases. | |
BRPI0817482B8 (en) | use of an interleukin-6 (il-6) receptor antibody in the treatment of graft versus host disease (gvhd) | |
GT200500363A (en) | 3-AMINO-PIRAZOL [3,4B] PIRIDINES WITH PROTEINTIROSINKINASE INHIBITORS, THEIR PREPARATION AND USE AS A MEDICINAL PRODUCT. | |
ATE509019T1 (en) | BENZODIAZEPINE PIROHYDANTOINS AS CGRP RECEPTOR ANTAGONISTS | |
DE602004013563D1 (en) | RANTAGONISTEN | |
UY27793A1 (en) | PIRAZOLOPIRIDINS SUBSTITUTED WITH CARBAMATE | |
DE602005021696D1 (en) | INDAZOLCARBONSÄUREAMIDVERBINDUNGEN | |
CL2021002503A1 (en) | Anti-tryptase antibodies, compositions of these and uses of these. (request divisional 201902251) | |
ATE441646T1 (en) | 5-HT4 RECEPTOR AGONIST COMPOUNDS | |
DE602005014566D1 (en) | Quinolinone-carboxamide CONNECTIONS | |
AR049876A1 (en) | PHARMACEUTICAL COMPOSITIONS TO TREAT SKIN DISEASES THAT INCLUDE A COMBINATION OF EPINASTINE AND ONE OR MORE ADDITIONAL MINERALS OR ONE OR MORE GROSS PHARMACOS | |
NO20024646D0 (en) | Combination therapies with vasculature-damaging activity | |
AR030554A1 (en) | SIMILAR MOLECULES TO IL-17 RECEPTORS AND USES OF THE SAME | |
CO5690618A2 (en) | THERAPEUTIC AGENT FOR MESOTELIOMA | |
ECSP045297A (en) | MICROGLY INHIBITORS TO INTERRUPT IMMUNE REACTIONS ASSOCIATED WITH INTERLEUCINE 12 AND IFN? | |
ECSP055917A (en) | DERIVATIVES OF USEFUL DIAZEPANES AS LFA INHIBITORS | |
UY26945A1 (en) | PHENOXYPHENYL ALCANOSULPHONATES | |
SE0001631D0 (en) | New use | |
FR2809725B1 (en) | PROPANOLAMINOTETRALINS, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME |